GeneIII仅三生物获评新华致敬·2025江苏科创领军示范案例

Core Insights - The article highlights the recognition of GeneIII Biotechnology as a leading example in the field of synthetic biology during the 16th Xinhua Summit, emphasizing its innovative contributions and industry leadership in the production of ergothioneine [1][3][6]. Group 1: Company Overview - GeneIII Biotechnology focuses on synthetic biology technology, specializing in the research, production, and application of ergothioneine, a popular antioxidant linked to various age-related degenerative diseases [5][6]. - The company has established a comprehensive industrial platform that includes strain construction, fermentation, purification, and large-scale production, achieving 99.99% purity of ergothioneine [5][6]. Group 2: Clinical Research and Validation - GeneIII is pioneering a shift in the dietary supplement industry by conducting rigorous clinical trials registered with the National Health Commission, moving from marketing-driven approaches to evidence-based validation [8][9]. - The company has completed significant clinical studies demonstrating the efficacy of ergothioneine in improving liver function and alleviating dry eye symptoms, with results showing statistically significant differences [8][9]. Group 3: International Collaboration and Research Network - In 2025, GeneIII established strategic partnerships with the National University of Singapore and the Temasek Life Sciences Laboratory, launching a global evidence-based research initiative for ergothioneine [11][13]. - The collaboration with renowned scientists aims to explore the cellular mechanisms and applications of ergothioneine in women's reproductive health, enhancing the company's global scientific credibility [13][14]. Group 4: Corporate Culture and Values - GeneIII emphasizes a corporate philosophy centered around the "Four Satisfactions"—social, shareholder, employee, and customer satisfaction—as a foundation for sustainable development and innovation [14][15]. - This cultural approach aims to attract top talent, foster internal cohesion, and build external trust, positioning the company for long-term success in the competitive synthetic biology sector [15].